Medical Dermatology
From the Journals
Antibiotics and SJS/TEN: Study provides global prevalence
Sulfonamides responsible for the highest proportion of antibiotic-triggered Stevens-Johnson syndrome and toxic epidermal necrolysis.
The Optimized Doctor
Could ChatGPT write this column?
I asked ChatGPT to write an article about itself in the style of Christopher Hitchens. It was nothing like his incisive and eloquent prose, but it...
Latest News
Secukinumab shows benefit for hidradenitis suppurativa out to 52 weeks
“In my experience, optimizing treatment can take almost a year and I hope we will see longer controlled periods in future studies,” Dr. Alexa B....
Latest News
Notalgia paresthetica: Difelikefalin helps upper-back itch, but with side effects
The main side effects reported included headaches, dizziness, constipation and increased urine output.
Make the Diagnosis
A White male presented with a 1½-year history of a progressive hypoesthetic annular, hyperpigmented plaque on the upper arm
A patient presents with a subtle, solitary 4-cm annular skin-colored thin plaque on his left posterior upper arm.
Latest News
Developments in wound healing include different treatment options
The TNF blocker infliximab is among the options to consider when treating pyoderma gangrenosum, according to Hadar Lev-Tov, MD...
Latest News
Expert gives tips on less-discussed dermatologic diseases
These diseases are important not to miss and can “also be quite challenging when we think about their management.”
Make the Diagnosis
A 50-year-old woman with no significant history presented with erythematous, annular plaques, and papules on the dorsal hands and arms
A 50-year-old has had erythematous, annular plaques, and papules on her hands and arms for years.
Latest News
Small study finds high dose vitamin D relieved toxic erythema of chemotherapy
Five of the six patients had a hematologic condition that required induction chemotherapy before hematopoietic stem cell transplant.
Latest News
New PDT therapy for CTCL to be reviewed by FDA
The treatment has received orphan drug and fast track designations from the FDA, and orphan designation from the European Medicines Agency,...
Feature
Have you heard of VEXAS syndrome?
The prevalence of this syndrome is unknown, but it is not so rare.